AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
May 26, 2011
30016_dirs_2011-05-26_e18d4ae5-0dfb-4048-bafd-713d2dd8032c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-05-25
Reporting Person: DEADY CONAN R (Corp VP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-25 | Common Stock | M | 9764 | $28.655 | Acquired | 29111 | Direct |
| 2011-05-25 | Common Stock | M | 2368 | $38.335 | Acquired | 31479 | Direct |
| 2011-05-25 | Common Stock | M | 218 | $41.935 | Acquired | 31697 | Direct |
| 2011-05-25 | Common Stock | M | 105 | $41.935 | Acquired | 31802 | Direct |
| 2011-05-25 | Common Stock | M | 7545 | $34.37 | Acquired | 39347 | Direct |
| 2011-05-25 | Common Stock | S | 20000 | $77.2575 | Disposed | 19347 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-25 | Non-Qualified Stock Option (right to buy) | $28.655 | M | 9764 | Disposed | 2015-02-02 | Common Stock (9764) | Direct |
| 2011-05-25 | Incentive Stock Option (right to buy) | $38.335 | M | 2368 | Disposed | 2013-02-13 | Common Stock (2368) | Direct |
| 2011-05-25 | Incentive Stock Option (right to buy) | $41.935 | M | 218 | Disposed | 2014-02-13 | Common Stock (218) | Direct |
| 2011-05-25 | Non-Qualified Stock Option (right to buy) | $41.935 | M | 105 | Disposed | 2014-02-13 | Common Stock (105) | Direct |
| 2011-05-25 | Non-Qualified Stock Option (right to buy) | $34.37 | M | 7545 | Disposed | 2016-02-13 | Common Stock (7545) | Direct |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/09/2011.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.00 to $77.56, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 4,400 shares on 02/03/2006, 02/03/2007, 02/03/2008, 02/03/2009, and the remaining 912 shares on 02/03/2010.
F4: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2011) of the grant.
F5: Grant of options to buy shares of common stock becomes exercisable as to 218 shares on 02/14/2011, and the remaining 2,384 shares on 02/14/2012.
F6: Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, 3,870 shares on 02/14/2011, and the remaining 1,704 shares on 02/14/2012.
F7: Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010, 02/14/2013, 3,773 shares on 02/14/2011, 02/14/2012, and the remaining 863 shares on 02/14/2014.